Introduction
Incidence of Type II Diabetes Mellitus (T2DM) is rising; majority of T2DM is managed in primary care. NICE recommends starting Metformin as a first-line therapy 1 . Studies have linked Metformin use with Vitamin B12 deficiency and suggest that regular monitoring of levels is warranted 2 . The pathogenesis is not fully understood. Literature suggests that the risk of developing B12 deficiency is greatly influenced by high doses and long duration of therapy 2, 3 .
Guidelines:
• 
NICE Guidelines:
•If Vitamin B12 is low then check for Intrinsic factor antibodies 5 •If these are negative, then the cause is not pernicious anaemia-most likely Metformin in this case.
•Seek urgent haematology advice if pt has neurological symptoms or is pregnant or if haematological malignancy suspected •For people with no neurological involvement:
1. Initially administer hydroxocobalamin 1 mg IM -3 times a week for the first 2 weeks. 2. Maintenance dose-administer hydroxocobalamin 1 mg IM every 3 months for life
Phase 2 Results:
Compliance to blood test= 72.2% 5 patients found to be Vitamin B12 deficient 3 out of 5 patients were anaemic too Phase 1+2: 15 out of 157 were deficient = 9.6% 
